Senior insider sale
President and CEO at VERA THERAPEUTICS, INC. — senior position signals high conviction
$1.71M
39.88K shares
What this filing means
FORDYCE MARSHALL plans to sell 39.88K shares of VERA THERAPEUTICS, INC. valued at approximately $1.71M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/14/2026ACC: 0001950047-26-003436
DirectorOfficer· President and CEO
Since May 2021
39.88K
Shares to sell
$1.71M
Approx. market value
22.95K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
2/20/2026
22.95KTotal acquired22.95K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/20/2026 | Restricted Stock Units N/A | 22.95K | — |
| Total | 22.95K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
16.93K
Market value
$710.6K
2/23/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
22.95K
Market value
$1.00M
4/14/2026
Total
Units
39.88K
Value
$1.71M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/23/2026 | 16.93K | $710.6K | — | Completed |
| Planned — Approximate Date | ||||
4/14/2026 | 22.95K | $1.00M | NASDAQ | Planned |
| Total | 39.88K | $1.71M | ||